Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -35,879 | N/A | N/A |
| Depreciation Amortization | 537 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,435 | N/A | N/A |
| Other Working Capital | 4,255 | N/A | N/A |
| Other Operating Activity | 4,599 | 0 | 0 |
| Operating Cash Flow | $-23,053 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -3,389 | N/A | N/A |
| Investing Cash Flow | $-3,389 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 60,060 | 0 | 0 |
| Financing Cash Flow | $60,060 | $N/A | $N/A |
| Beginning Cash Position | 9,245 | N/A | N/A |
| End Cash Position | 42,863 | N/A | N/A |
| Net Cash Flow | $33,618 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -23,053 | N/A | N/A |
| Capital Expenditure | -3,389 | N/A | N/A |
| Free Cash Flow | -26,442 | 0 | 0 |